Case
Project background
Our client encountered significant challenges in navigating the reimbursement system for their innovative product, which targets two distinct indications. Initially, they chose an incorrect reimbursement route, putting the success of their product launch at risk. A comprehensive market access scan helped to reassess and correct their strategy, saving invaluable time and resources by redirecting their approach toward the optimal reimbursement pathway.
Challenges faced
The client aimed to secure an optimal reimbursement request supported by a compelling therapeutic value claim. However, the complexity of the Dutch reimbursement system, coupled with their limited familiarity and the pressure of tight timelines, created a high risk of overlooking critical details. This increased the likelihood of encountering rejections, delays, and missed opportunities—ultimately threatening the timely launch and success of their product in the market.